No profile data available.
Quince Therapeutics, Inc. (QNCX) is a healthcare company in the brain and nerve treatment drugs industry, based in South San Francisco, United States, with about 38 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$83.98 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $32.27 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a biotechnology company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases.
Quince Therapeutics reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$32.27 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Annovis Bio, Inc. (ANVS), CervoMed Inc. (CRVO), Incannex Healthcare Inc. (IXHL), Mira Pharmaceuticals, Inc. (MIRA).